-
Research findings indicate that brief telephone counseling sustained long-term impact from a sexually transmitted infections/HIV intervention program among African American female adolescents.
-
The North American Menopause Society and the International Society for the Study of Women’s Sexual Health have developed and endorsed the term “genitourinary syndrome of menopause” (GSM) to define “a collection of symptoms and signs associated with a decrease in estrogen and other sex steroids involving changes to the labia majora/minora, clitoris, vestibule/introitus, vagina, urethra and bladder.”
-
Research findings from the Contraceptive CHOICE Project, a St. Louis prospective cohort study, examined the short-term bleeding and cramping patterns of long-acting reversible contraception (LARC) methods and the impact on method satisfaction.
-
Women in the West African nation of Burkina Faso now have access to a lower-dose formulation of depot medroxyprogesterone acetate (DMPA) packaged in a novel injection system that is designed to increase access to contraception at all levels of the health system.
-
Prolapse occurs along a spectrum from early and asymptomatic to advanced and symptomatic. The authors define anatomic cutoffs that are likely to result in symptomatic and clinically significant prolapse.
-
Barriers to guideline-adherent care for advanced ovarian cancer are impacted by geographic proximity to a high-volume hospital and travel distance. However, these geographic barriers disproportionately affect racial minorities and women of lower socioeconomic status.
-
In this prospective cohort study of 161 nulligravid women, there was no reliable threshold of uterine length or flexion angle measurements that were predictive of painful or difficult insertions. History of severe dysmenorrhea was the only predictor of insertion pain.
-
News from the KEEPS Study: HRT Does Not Decrease Progression of Atherosclerosis Over 4 Years of Treatment
-
American College of Obstetrics and Gynecologists (ACOG) recently published updated recommendations on the frequency of cervical cytology screening.
-
In this issue: Results from a Phase 3 study of dabigatran, intensive lipid-lowering in CVD, H1N1 vaccine dosing and efficacy, and FDA Actions.